STRIVE Post-Market Registry Study (NCT04302272)
The Spiration® Valve System (SVS) Post-Market Registry Study for Severe Emphysema
🩺 Plain-English Summary (8th-Grade Level)
This is a single-arm, prospective, multi-center, Registry study to evaluate the long-term safety and effectiveness of the Spiration Valve System (SVS) for the treatment of severe emphysema in a post-market setting.
Who can join: Review the eligibility criteria below.
Location: Dignity Health St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (16 Sites)
- Dignity Health St. Joseph's Hospital and Medical Center — Phoenix, Arizona
- El Camino, Taft Center for Clinical Research — Mountain View, California
- University of Miami — Coral Gables, Florida
- Northwestern University, Division of Pulmonary and Critical Care Medicine — Chicago, Illinois
- University of Chicago — Chicago, Illinois
- LSU Health Shreveport — Shreveport, Louisiana
- University of Maryland — Baltimore, Maryland
- Beth Israel Decaconess — Boston, Massachusetts
- Memorial Hospital at Gulfport — Gulfport, Mississippi
- Duke University Medical Center — Durham, North Carolina
- Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania
- Temple University — Philadelphia, Pennsylvania
- AnMed Health — Anderson, South Carolina
- Baylor Scott & White Research Institute — Dallas, Texas
- University of Texas Southwestern — Dallas, Texas
- University of Texas Health Science Center at Houston — Houston, Texas
📞 Contact the Study Coordinator
Phone: (703) 201-0680
Email: courtney.inge@olympus.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Emphysema
- Doxycycline for Emphysema in People Living With HIV (The DEPTH Trial) — Birmingham, Alabama
- Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema — Iowa City, Iowa
- Zephyr Valve Registry (ZEVR) — Birmingham, Alabama
- Emphysema Research Registry and Biosample Repository — Pittsburgh, Pennsylvania
- Characterizing Matrix Metalloproteinase-12 (MMP12) in Sputum — Hamilton, Ontario
Explore by condition: All Emphysema clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.